GeoVax Labs

GOVXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.674 M

$0.77 +6.75%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$21.5M

Loss-making

Shares outstanding

7,369,243

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#464PulmatrixPULM$6.06M
#465GelteqGELS$5.98M
#466GeoVax LabsGOVX$5.67M
#467Curanex PharmaceuticalsCURX$5.53M
#468Lakewood-Amedex BiotherapeuticsLABT$5.26M

Where these numbers come from

Share counts and financials for GeoVax Labs are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.